Vivitrol for Opiate Addiction: Biotech Firm Alkermes Poised to Swell on Pipeline Wins ALKS JNJ BMY
Biotech Firm Alkermes Poised To Swell On Pipeline Wins ALKS JNJ BMY
Filed under: vivitrol for opiate addiction
Alkermes receives royalties from partners on all but one of those five drugs, Vivitrol, a once-monthly drug to treat alcohol and opioid dependence. Alkermes markets Vivitrol itself. The product generated $ 15.9 million in Q3 revenue, up from $ 10.6 …
Source
Alkermes Gains as Depression Drug Meets Study Goals
Filed under: vivitrol for opiate addiction
Alkermes Plc (ALKS), the maker of the alcohol-dependence treatment Vivitrol, rose to an 11-year high in U.S. trading after the company said its experimental drug for major depressive disorder met goals of a mid-stage trial. Alkermes gained 16 percent …
Source
Related Vivitrol For Opiate Addiction Information…